Cargando…
Drug approval status and recommendations for listing on public formularies: a Canadian cohort analysis
OBJECTIVES: Investigate if the recommendations by the Common Drug Review (CDR) and the pan-Canadian Oncology Drug Review (pCODR) to provincial, territorial and federal drug plans about whether to list non-oncology and oncology drug-indication combinations on their formularies are associated with whe...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665246/ https://www.ncbi.nlm.nih.gov/pubmed/29061631 http://dx.doi.org/10.1136/bmjopen-2017-018372 |